Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis

Solomon, D. H., Giles, J. T., Liao, K. P., Ridker, P. M., Rist, P. M., Glynn, R. J., Broderick, R., Lu, F., Murray, M. T., Vanni, K., Santacroce, L. M., Abohashem, S., Robson, P. M., Fayad, Z., Mani, V., Tawakol, A., & Bathon, J. (2022). Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 82(3), 324–330. https://doi.org/10.1136/ard-2022-223302
Authors:
Daniel H Solomon
Jon T Giles
Katherine P Liao
Paul M Ridker
Pamela M Rist
Robert J Glynn
Rachel Broderick
Fengxin Lu
Meredith T Murray
Kathleen Vanni
Leah M Santacroce
Shady Abohashem
Philip M Robson
Zahi Fayad
Venkatesh Mani
Ahmed Tawakol
Joan Bathon
Affiliated Authors:
Jon T Giles
Rachel Broderick
Joan Bathon
Author Keywords:
arthritis
rheumatoid
cardiovascular diseases
tumor necrosis factor inhibitors
arthritis, rheumatoid
Publication Type:
Article
Unique ID:
10.1136/ard-2022-223302
PMID:
Publication Date:
Data Source:
PubMed

Record Created: